Loading…

Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis

Background While the relevance of the World Health Organization histopathological grading system as a prognostic tool for oral squamous cell carcinoma has received many critics, other histopathological features such as tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding are display...

Full description

Saved in:
Bibliographic Details
Published in:Journal of oral pathology & medicine 2023-05, Vol.52 (5), p.402-409
Main Authors: Silva, Gabriela Vivili Domingues, Silva Dolens, Eder, Paranaíba, Lívia Máris Ribeiro, Ayroza, Ana Lúcia Carrinho, Gurgel Rocha, Clarissa Araujo, Almangush, Alhadi, Salo, Tuula, Brennan, Peter A., Coletta, Ricardo D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3889-e99ad2790195c5f1bc0fcf85effef490979a4f3234c88f23811ac483798ce7b13
cites cdi_FETCH-LOGICAL-c3889-e99ad2790195c5f1bc0fcf85effef490979a4f3234c88f23811ac483798ce7b13
container_end_page 409
container_issue 5
container_start_page 402
container_title Journal of oral pathology & medicine
container_volume 52
creator Silva, Gabriela Vivili Domingues
Silva Dolens, Eder
Paranaíba, Lívia Máris Ribeiro
Ayroza, Ana Lúcia Carrinho
Gurgel Rocha, Clarissa Araujo
Almangush, Alhadi
Salo, Tuula
Brennan, Peter A.
Coletta, Ricardo D.
description Background While the relevance of the World Health Organization histopathological grading system as a prognostic tool for oral squamous cell carcinoma has received many critics, other histopathological features such as tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding are displaying promising results. Here, we evaluated the prognostic impact of the incorporation of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding into World Health Organization histopathological grading for patients with oral squamous cell carcinoma. Methods A total of 95 patients with early‐stage oral squamous cell carcinoma were enrolled in the study, and World Health Organization tumor grading, tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding were evaluated in surgical slides stained with hematoxylin and eosin. Survival analyses for cancer‐specific survival and disease‐free survival were performed using Cox regression models, and receiver operating characteristic curves were applied for assessment of the performance of the combinations. Results Tumor‐stroma ratio (stroma‐rich) was significantly and independently associated with both shortened cancer‐specific survival and poor disease‐free survival, individually and in combination with World Health Organization histopathological grading. The combination of tumor‐stroma ratio with World Health Organization grading did not improve the discriminatory ability compared to tumor‐stroma ratio alone. Although low tumor‐infiltrating lymphocytes were associated with shortened cancer‐specific survival, the association did not withstand multivariate analysis. However, in combination with World Health Organization grading, low tumor‐infiltrating lymphocytes were independently associated with poor cancer‐specific survival. The combination of tumor‐infiltrating lymphocytes and World Health Organization histopathological grading displayed a better discrimination of poor cancer‐specific survival than tumor‐infiltrating lymphocytes alone, but not at a significant level. Conclusion Our findings support tumor‐stroma ratio as a potential prognostic marker for patients with oral squamous cell carcinoma, and the incorporation of tumor‐infiltrating lymphocytes into the World Health Organization grading system improves the prognostic ability of the tumor grading alone.
doi_str_mv 10.1111/jop.13359
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2717694722</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2717694722</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3889-e99ad2790195c5f1bc0fcf85effef490979a4f3234c88f23811ac483798ce7b13</originalsourceid><addsrcrecordid>eNp1kUFu1DAYhS0EokNhwQWQJTYgNa0dJ2N7iapCW1UaFiCWkePYiUdOnNqOSnYcgStxFU6CMyldVKo3lv73_e9_0gPgLUanOL2zvRtPMSElfwY2eItQhigunoMN4qjI8hLnR-BVCHuEMCUFfgmOyBYXnJblBvy5-Dla583QwtgpKF1fm0FE4wboNIxT7_zfX79D9K4X0C_CycPUDNrYuAzTtp37sXNyjiqcQDE0KwXrqWkW-c7EDv643MHOhOhGETtnXWuksLD14oCkk0p4Ox_uiVZB55MabifRuylAqayFUnhphiXL6F07uGDCa_BCCxvUm_v_GHz_fPHt_DK72X25Ov90k0nCGM8U56LJKUeYl7LUuJZIS81KpbXSBUecclFokpNCMqZzwjAWsmCEciYVrTE5Bh9W33T5dlIhVr0JSygxqJSvyimmW17QPE_o-0fo3k1-SOmqnGGyRQSxhfq4UtK7ELzS1ehNL_xcYVQtvaatsTr0mth3945T3avmgfxfZALOVuDOWDU_7VRd776ulv8AKYy0zA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2813603082</pqid></control><display><type>article</type><title>Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis</title><source>Wiley</source><creator>Silva, Gabriela Vivili Domingues ; Silva Dolens, Eder ; Paranaíba, Lívia Máris Ribeiro ; Ayroza, Ana Lúcia Carrinho ; Gurgel Rocha, Clarissa Araujo ; Almangush, Alhadi ; Salo, Tuula ; Brennan, Peter A. ; Coletta, Ricardo D.</creator><creatorcontrib>Silva, Gabriela Vivili Domingues ; Silva Dolens, Eder ; Paranaíba, Lívia Máris Ribeiro ; Ayroza, Ana Lúcia Carrinho ; Gurgel Rocha, Clarissa Araujo ; Almangush, Alhadi ; Salo, Tuula ; Brennan, Peter A. ; Coletta, Ricardo D.</creatorcontrib><description>Background While the relevance of the World Health Organization histopathological grading system as a prognostic tool for oral squamous cell carcinoma has received many critics, other histopathological features such as tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding are displaying promising results. Here, we evaluated the prognostic impact of the incorporation of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding into World Health Organization histopathological grading for patients with oral squamous cell carcinoma. Methods A total of 95 patients with early‐stage oral squamous cell carcinoma were enrolled in the study, and World Health Organization tumor grading, tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding were evaluated in surgical slides stained with hematoxylin and eosin. Survival analyses for cancer‐specific survival and disease‐free survival were performed using Cox regression models, and receiver operating characteristic curves were applied for assessment of the performance of the combinations. Results Tumor‐stroma ratio (stroma‐rich) was significantly and independently associated with both shortened cancer‐specific survival and poor disease‐free survival, individually and in combination with World Health Organization histopathological grading. The combination of tumor‐stroma ratio with World Health Organization grading did not improve the discriminatory ability compared to tumor‐stroma ratio alone. Although low tumor‐infiltrating lymphocytes were associated with shortened cancer‐specific survival, the association did not withstand multivariate analysis. However, in combination with World Health Organization grading, low tumor‐infiltrating lymphocytes were independently associated with poor cancer‐specific survival. The combination of tumor‐infiltrating lymphocytes and World Health Organization histopathological grading displayed a better discrimination of poor cancer‐specific survival than tumor‐infiltrating lymphocytes alone, but not at a significant level. Conclusion Our findings support tumor‐stroma ratio as a potential prognostic marker for patients with oral squamous cell carcinoma, and the incorporation of tumor‐infiltrating lymphocytes into the World Health Organization grading system improves the prognostic ability of the tumor grading alone.</description><identifier>ISSN: 0904-2512</identifier><identifier>EISSN: 1600-0714</identifier><identifier>DOI: 10.1111/jop.13359</identifier><identifier>PMID: 36149755</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Cancer ; Carcinoma, Squamous Cell - pathology ; Head and Neck Neoplasms - pathology ; histopathological features ; Humans ; Lymphocytes ; Lymphocytes, Tumor-Infiltrating ; Medical prognosis ; Mouth Neoplasms - pathology ; Multivariate analysis ; Neoplasm Grading ; Neoplasm Staging ; Oral cancer ; Oral carcinoma ; Oral squamous cell carcinoma ; Prognosis ; Regression analysis ; Retrospective Studies ; Squamous cell carcinoma ; Squamous Cell Carcinoma of Head and Neck - pathology ; Stroma ; tumor budding ; Tumors ; tumor‐stroma ratio ; WHO grading system ; World Health Organization</subject><ispartof>Journal of oral pathology &amp; medicine, 2023-05, Vol.52 (5), p.402-409</ispartof><rights>2022 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>2023 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3889-e99ad2790195c5f1bc0fcf85effef490979a4f3234c88f23811ac483798ce7b13</citedby><cites>FETCH-LOGICAL-c3889-e99ad2790195c5f1bc0fcf85effef490979a4f3234c88f23811ac483798ce7b13</cites><orcidid>0000-0001-5285-3046</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36149755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Silva, Gabriela Vivili Domingues</creatorcontrib><creatorcontrib>Silva Dolens, Eder</creatorcontrib><creatorcontrib>Paranaíba, Lívia Máris Ribeiro</creatorcontrib><creatorcontrib>Ayroza, Ana Lúcia Carrinho</creatorcontrib><creatorcontrib>Gurgel Rocha, Clarissa Araujo</creatorcontrib><creatorcontrib>Almangush, Alhadi</creatorcontrib><creatorcontrib>Salo, Tuula</creatorcontrib><creatorcontrib>Brennan, Peter A.</creatorcontrib><creatorcontrib>Coletta, Ricardo D.</creatorcontrib><title>Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis</title><title>Journal of oral pathology &amp; medicine</title><addtitle>J Oral Pathol Med</addtitle><description>Background While the relevance of the World Health Organization histopathological grading system as a prognostic tool for oral squamous cell carcinoma has received many critics, other histopathological features such as tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding are displaying promising results. Here, we evaluated the prognostic impact of the incorporation of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding into World Health Organization histopathological grading for patients with oral squamous cell carcinoma. Methods A total of 95 patients with early‐stage oral squamous cell carcinoma were enrolled in the study, and World Health Organization tumor grading, tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding were evaluated in surgical slides stained with hematoxylin and eosin. Survival analyses for cancer‐specific survival and disease‐free survival were performed using Cox regression models, and receiver operating characteristic curves were applied for assessment of the performance of the combinations. Results Tumor‐stroma ratio (stroma‐rich) was significantly and independently associated with both shortened cancer‐specific survival and poor disease‐free survival, individually and in combination with World Health Organization histopathological grading. The combination of tumor‐stroma ratio with World Health Organization grading did not improve the discriminatory ability compared to tumor‐stroma ratio alone. Although low tumor‐infiltrating lymphocytes were associated with shortened cancer‐specific survival, the association did not withstand multivariate analysis. However, in combination with World Health Organization grading, low tumor‐infiltrating lymphocytes were independently associated with poor cancer‐specific survival. The combination of tumor‐infiltrating lymphocytes and World Health Organization histopathological grading displayed a better discrimination of poor cancer‐specific survival than tumor‐infiltrating lymphocytes alone, but not at a significant level. Conclusion Our findings support tumor‐stroma ratio as a potential prognostic marker for patients with oral squamous cell carcinoma, and the incorporation of tumor‐infiltrating lymphocytes into the World Health Organization grading system improves the prognostic ability of the tumor grading alone.</description><subject>Cancer</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>histopathological features</subject><subject>Humans</subject><subject>Lymphocytes</subject><subject>Lymphocytes, Tumor-Infiltrating</subject><subject>Medical prognosis</subject><subject>Mouth Neoplasms - pathology</subject><subject>Multivariate analysis</subject><subject>Neoplasm Grading</subject><subject>Neoplasm Staging</subject><subject>Oral cancer</subject><subject>Oral carcinoma</subject><subject>Oral squamous cell carcinoma</subject><subject>Prognosis</subject><subject>Regression analysis</subject><subject>Retrospective Studies</subject><subject>Squamous cell carcinoma</subject><subject>Squamous Cell Carcinoma of Head and Neck - pathology</subject><subject>Stroma</subject><subject>tumor budding</subject><subject>Tumors</subject><subject>tumor‐stroma ratio</subject><subject>WHO grading system</subject><subject>World Health Organization</subject><issn>0904-2512</issn><issn>1600-0714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp1kUFu1DAYhS0EokNhwQWQJTYgNa0dJ2N7iapCW1UaFiCWkePYiUdOnNqOSnYcgStxFU6CMyldVKo3lv73_e9_0gPgLUanOL2zvRtPMSElfwY2eItQhigunoMN4qjI8hLnR-BVCHuEMCUFfgmOyBYXnJblBvy5-Dla583QwtgpKF1fm0FE4wboNIxT7_zfX79D9K4X0C_CycPUDNrYuAzTtp37sXNyjiqcQDE0KwXrqWkW-c7EDv643MHOhOhGETtnXWuksLD14oCkk0p4Ox_uiVZB55MabifRuylAqayFUnhphiXL6F07uGDCa_BCCxvUm_v_GHz_fPHt_DK72X25Ov90k0nCGM8U56LJKUeYl7LUuJZIS81KpbXSBUecclFokpNCMqZzwjAWsmCEciYVrTE5Bh9W33T5dlIhVr0JSygxqJSvyimmW17QPE_o-0fo3k1-SOmqnGGyRQSxhfq4UtK7ELzS1ehNL_xcYVQtvaatsTr0mth3945T3avmgfxfZALOVuDOWDU_7VRd776ulv8AKYy0zA</recordid><startdate>202305</startdate><enddate>202305</enddate><creator>Silva, Gabriela Vivili Domingues</creator><creator>Silva Dolens, Eder</creator><creator>Paranaíba, Lívia Máris Ribeiro</creator><creator>Ayroza, Ana Lúcia Carrinho</creator><creator>Gurgel Rocha, Clarissa Araujo</creator><creator>Almangush, Alhadi</creator><creator>Salo, Tuula</creator><creator>Brennan, Peter A.</creator><creator>Coletta, Ricardo D.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5285-3046</orcidid></search><sort><creationdate>202305</creationdate><title>Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis</title><author>Silva, Gabriela Vivili Domingues ; Silva Dolens, Eder ; Paranaíba, Lívia Máris Ribeiro ; Ayroza, Ana Lúcia Carrinho ; Gurgel Rocha, Clarissa Araujo ; Almangush, Alhadi ; Salo, Tuula ; Brennan, Peter A. ; Coletta, Ricardo D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3889-e99ad2790195c5f1bc0fcf85effef490979a4f3234c88f23811ac483798ce7b13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cancer</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>histopathological features</topic><topic>Humans</topic><topic>Lymphocytes</topic><topic>Lymphocytes, Tumor-Infiltrating</topic><topic>Medical prognosis</topic><topic>Mouth Neoplasms - pathology</topic><topic>Multivariate analysis</topic><topic>Neoplasm Grading</topic><topic>Neoplasm Staging</topic><topic>Oral cancer</topic><topic>Oral carcinoma</topic><topic>Oral squamous cell carcinoma</topic><topic>Prognosis</topic><topic>Regression analysis</topic><topic>Retrospective Studies</topic><topic>Squamous cell carcinoma</topic><topic>Squamous Cell Carcinoma of Head and Neck - pathology</topic><topic>Stroma</topic><topic>tumor budding</topic><topic>Tumors</topic><topic>tumor‐stroma ratio</topic><topic>WHO grading system</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Silva, Gabriela Vivili Domingues</creatorcontrib><creatorcontrib>Silva Dolens, Eder</creatorcontrib><creatorcontrib>Paranaíba, Lívia Máris Ribeiro</creatorcontrib><creatorcontrib>Ayroza, Ana Lúcia Carrinho</creatorcontrib><creatorcontrib>Gurgel Rocha, Clarissa Araujo</creatorcontrib><creatorcontrib>Almangush, Alhadi</creatorcontrib><creatorcontrib>Salo, Tuula</creatorcontrib><creatorcontrib>Brennan, Peter A.</creatorcontrib><creatorcontrib>Coletta, Ricardo D.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oral pathology &amp; medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Silva, Gabriela Vivili Domingues</au><au>Silva Dolens, Eder</au><au>Paranaíba, Lívia Máris Ribeiro</au><au>Ayroza, Ana Lúcia Carrinho</au><au>Gurgel Rocha, Clarissa Araujo</au><au>Almangush, Alhadi</au><au>Salo, Tuula</au><au>Brennan, Peter A.</au><au>Coletta, Ricardo D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis</atitle><jtitle>Journal of oral pathology &amp; medicine</jtitle><addtitle>J Oral Pathol Med</addtitle><date>2023-05</date><risdate>2023</risdate><volume>52</volume><issue>5</issue><spage>402</spage><epage>409</epage><pages>402-409</pages><issn>0904-2512</issn><eissn>1600-0714</eissn><abstract>Background While the relevance of the World Health Organization histopathological grading system as a prognostic tool for oral squamous cell carcinoma has received many critics, other histopathological features such as tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding are displaying promising results. Here, we evaluated the prognostic impact of the incorporation of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding into World Health Organization histopathological grading for patients with oral squamous cell carcinoma. Methods A total of 95 patients with early‐stage oral squamous cell carcinoma were enrolled in the study, and World Health Organization tumor grading, tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding were evaluated in surgical slides stained with hematoxylin and eosin. Survival analyses for cancer‐specific survival and disease‐free survival were performed using Cox regression models, and receiver operating characteristic curves were applied for assessment of the performance of the combinations. Results Tumor‐stroma ratio (stroma‐rich) was significantly and independently associated with both shortened cancer‐specific survival and poor disease‐free survival, individually and in combination with World Health Organization histopathological grading. The combination of tumor‐stroma ratio with World Health Organization grading did not improve the discriminatory ability compared to tumor‐stroma ratio alone. Although low tumor‐infiltrating lymphocytes were associated with shortened cancer‐specific survival, the association did not withstand multivariate analysis. However, in combination with World Health Organization grading, low tumor‐infiltrating lymphocytes were independently associated with poor cancer‐specific survival. The combination of tumor‐infiltrating lymphocytes and World Health Organization histopathological grading displayed a better discrimination of poor cancer‐specific survival than tumor‐infiltrating lymphocytes alone, but not at a significant level. Conclusion Our findings support tumor‐stroma ratio as a potential prognostic marker for patients with oral squamous cell carcinoma, and the incorporation of tumor‐infiltrating lymphocytes into the World Health Organization grading system improves the prognostic ability of the tumor grading alone.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36149755</pmid><doi>10.1111/jop.13359</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0001-5285-3046</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0904-2512
ispartof Journal of oral pathology & medicine, 2023-05, Vol.52 (5), p.402-409
issn 0904-2512
1600-0714
language eng
recordid cdi_proquest_miscellaneous_2717694722
source Wiley
subjects Cancer
Carcinoma, Squamous Cell - pathology
Head and Neck Neoplasms - pathology
histopathological features
Humans
Lymphocytes
Lymphocytes, Tumor-Infiltrating
Medical prognosis
Mouth Neoplasms - pathology
Multivariate analysis
Neoplasm Grading
Neoplasm Staging
Oral cancer
Oral carcinoma
Oral squamous cell carcinoma
Prognosis
Regression analysis
Retrospective Studies
Squamous cell carcinoma
Squamous Cell Carcinoma of Head and Neck - pathology
Stroma
tumor budding
Tumors
tumor‐stroma ratio
WHO grading system
World Health Organization
title Exploring the combination of tumor‐stroma ratio, tumor‐infiltrating lymphocytes, and tumor budding with WHO histopathological grading on early‐stage oral squamous cell carcinoma prognosis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T01%3A28%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Exploring%20the%20combination%20of%20tumor%E2%80%90stroma%20ratio,%20tumor%E2%80%90infiltrating%20lymphocytes,%20and%20tumor%20budding%20with%20WHO%20histopathological%20grading%20on%20early%E2%80%90stage%20oral%20squamous%20cell%20carcinoma%20prognosis&rft.jtitle=Journal%20of%20oral%20pathology%20&%20medicine&rft.au=Silva,%20Gabriela%20Vivili%20Domingues&rft.date=2023-05&rft.volume=52&rft.issue=5&rft.spage=402&rft.epage=409&rft.pages=402-409&rft.issn=0904-2512&rft.eissn=1600-0714&rft_id=info:doi/10.1111/jop.13359&rft_dat=%3Cproquest_cross%3E2717694722%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3889-e99ad2790195c5f1bc0fcf85effef490979a4f3234c88f23811ac483798ce7b13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2813603082&rft_id=info:pmid/36149755&rfr_iscdi=true